Published on in Vol 3, No 2 (2022): Apr-Jun
Preprints (earlier versions) of this paper are
available at
https://www.medrxiv.org/content/10.1101/2021.06.21.21258931v1, first published
.
![Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study](https://asset.jmir.pub/assets/45b2a64c2c57c9bd41069f67cbae77f1.png 480w,https://asset.jmir.pub/assets/45b2a64c2c57c9bd41069f67cbae77f1.png 960w,https://asset.jmir.pub/assets/45b2a64c2c57c9bd41069f67cbae77f1.png 1920w,https://asset.jmir.pub/assets/45b2a64c2c57c9bd41069f67cbae77f1.png 2500w)
Journals
- Hetti Arachchilage M. Peer Review of “Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study”. JMIRx Med 2022;3(2):e37513 View
- Tagwerker C, Carias-Marines M, Smith D. Authors' Response to Peer Reviews of “Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study”. JMIRx Med 2022;3(2):e37242 View
- Rathi K. Peer Review of “Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study”. JMIRx Med 2022;3(2):e37145 View